Recorded Wednesday, April 7th from 12:00 – 1:30 PM Pacific/3:00 – 4:30 PM Eastern

The concept of herd immunity has been applied for decades in epidemiology and public health, yet the COVID-19 pandemic has prompted new debate about the role of herd immunity in the pandemic response and confusion about what herd immunity entails.

Join a panel of experts who will explain the science of and misconceptions around herd immunity and discuss new research frontiers in immunology, infectious disease dynamics, and human behavior.

People in public arenas have seized on scientific uncertainty in the face of an emerging disease to argue that the fastest way out of the pandemic is to allow herd immunity to accumulate through natural infection in a minimally controlled epidemic; others have argued that herd immunity can be achieved at levels far below theoretically-determined thresholds.

With the introduction of safe and effective vaccines, it is important to understand how to evaluate progress toward herd immunity and what reaching herd immunity will mean within the context of the COVID-19 pandemic.

Marc Lipsitch – Professor of epidemiology and Director of the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health.Rustom Antia – Professor of biology at Emory University.Lauren Ancel Meyers – Professor of Integrative Biology and Statistics & Data Sciences at The University of Texas at Austin.

Julie Parsonnet – Professor in medicine and Professor of epidemiology and population health at Stanford University.

Erin Mordecai – Assistant Professor in biology at Stanford University.